医学
诊断生物标志物
疾病
神经学
生物标志物
病理
痴呆
信使核糖核酸
癌症研究
老年精神病学
发病机制
诊断试验
阿尔茨海默病
肾脏疾病
生物信息学
退行性疾病
内科学
作者
Ming Li,Qian Yu,Shuyi Yu,Qian Cheng,Siyu Wu,Yan Jin,Zhikang Cui,Hang Chen,Xinyu Zhao,Xiaoben Wu,Zhiming Lu
标识
DOI:10.1186/s13195-026-02034-3
摘要
Alzheimer’s disease (AD) is the most common form of dementia. However, there is a lack of effective diagnostic biomarkers to differentiate AD from non-Alzheimer’s (Non-AD) dementias, such as vascular dementia, Lewy body dementia, Parkinson’s disease dementia, and chronic traumatic encephalopathy. This study aims to evaluate the expression variations of LINE-1 retrotransposon in plasma EVs as a potential biomarker to differentiate between AD and Non-AD dementias and explore its diagnostic value in clinical practice. Here, we analyzed two independent clinical cohorts: a training cohort (AD: n = 139; Non-AD: n = 137; Control: n = 79) and a validation cohort (AD: n = 158; Non-AD: n = 133; Control: n = 61). Expression of LINE-1 mRNA in plasma EVs, containing ORF1, ORF2, and 5’UTR regions, was quantified using RT-qPCR, and the differences between control, AD and Non-AD groups were assessed by one-way ANOVA or non-parametric tests. In both training and validation cohorts, LINE-1 mRNA expression was significantly higher in AD patients compared to Non-AD patients and healthy control in the ORF1, 5’UTR, and ORF2 regions. LINE-1 expression was correlated with that of neuroinflammatory and neurodegeneration markers (GFAP and NfL), whereas no significant correlations were revealed between LINE-1 expression and cognitive scores. ROC analysis revealed that while LINE-1 was less effective than traditional biomarkers for general AD diagnosis, it demonstrated superior accuracy in differentiating AD from Non-AD dementias. Specifically, the AUC values for LINE-1_ORF2 and LINE-1_5’UTR were 0.91 and 0.92, respectively, significantly outperforming p-Tau217 (AUC = 0.80) and GFAP (AUC = 0.62) in the training cohort. Multivariate regression confirmed that the LINE-1 composite index was an independent predictor of AD. These findings suggest that the LINE-1 composite score, as an age-independent predictor, holds significant clinical potential for the differential diagnosis of AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI